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Outcome-related metabolomic patterns from
1H/31P NMR after mild hypothermia treatments
of oxygen–glucose deprivation in a neonatal
brain slice model of asphyxia
Jia Liu1, Lawrence Litt1, Mark R Segal2, Mark JS Kelly3, Hikari AI Yoshihara3 and
Thomas L James3
1Department of Anesthesia, University of California, San Francisco, California, USA; 2Department of
Epidemiology and Biostatistics, University of California, San Francisco, California, USA; 3Department of
Pharmaceutical Chemistry, University of California, San Francisco, California, USA
Human clinical trials using 72 hours of mild hypothermia (321C–341C) after neonatal asphyxia have
found substantially improved neurologic outcomes. As temperature changes differently modulate
numerous metabolite fluxes and concentrations, we hypothesized that 1H/31P nuclear magnetic
resonance (NMR) spectroscopy of intracellular metabolites can distinguish different insults,
treatments, and recovery stages. Three groups of superfused neonatal rat brain slices underwent
45minutes oxygen–glucose deprivation (OGD) and then were: treated for 3hours with mild
hypothermia (321C) that began with OGD, or similarly treated with hypothermia after a 15-minute
delay, or not treated (normothermic control group, 371C). Hypothermia was followed by 3hours of
normothermic recovery. Slices collected at different predetermined times were processed,
respectively, for 14.1 Tesla NMR analysis, enzyme-linked immunosorbent assay (ELISA) cell-death
quantification, and superoxide production. Forty-nine NMR-observable metabolites underwent a
multivariate analysis. Separated clustering in scores plots was found for treatment and outcome
groups. Final ATP (adenosine triphosphate) levels, severely decreased at normothermia, were
restored equally by immediate and delayed hypothermia. Cell death was decreased by immediate
hypothermia, but was equally substantially greater with normothermia and delayed hypothermia.
Potentially important biomarkers in the 1H spectra included PCr-1H (phosphocreatine in the
1H spectrum), ATP-1H (adenosine triphosphate in the 1H spectrum), and ADP-1H (adenosine
diphosphate in the 1H spectrum). The findings suggest a potential role for metabolomic monitoring
during therapeutic hypothermia.
Journal of Cerebral Blood Flow & Metabolism (2011) 31, 547–559; doi:10.1038/jcbfm.2010.125; published online
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Introduction
Two large randomized clinical trials recently found
that after neonatal asphyxia, 72 hours of mild brain
hypothermia (331C to 341C), begun no more than
6hours after birth, improves long-term neurologic
outcome. In the CoolCap study (Gluckman et al,
2005; Gunn et al, 1998), the scalp and underlying
tissues were cooled, whereas in a larger clinical trial
(Shankaran et al, 2005), the whole body was cooled.
This together with other evidence in human newborns
of improved neurologic outcomes (Compagnoni et al,
2002, 2008) has initiated a ‘surge’ in mechanism-
oriented hypothermia research projects. We believe
that important issues related to optimal cooling
temperatures, durations, rewarming regimens, and
mechanisms—and to the individualization of ther-
apy—would be better addressed if there were a
reliable way to identify and assess helpful and
harmful intracellular events during the many hours
of a hypothermia treatment.
We also believe that magnetic resonance spectro-
scopy (or nuclear magnetic resonance (NMR) spec-
troscopy) has enormous potential for ultimately
guiding therapeutic hypothermia in humans. One
of several NMR approaches involves metabolic
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profiling, or NMR metabolomics (sometimes referred
to as metabonomics), in which ensembles of
NMR metabolites, 49 in this study, are subjected to
multivariate analyses. As hypothermia differently
modulates the fluxes and concentrations of numer-
ous metabolites, it is reasonable to ask whether
substantial physiological changes that come from a
41C temperature change are associated with impress-
ive metabolic variations and changes in the charac-
teristics of specific metabolite ensembles. Such
might occur if important chemical activation energy
thresholds undergo large changes in the 41C tem-
perature range, as suggested by the Arrhenius
equation (as explained in the Appendix).
Methodological advances have already made it
possible to accurately obtain in vivo 14.1 Tesla NMR
quantifications in mice of 19 1H metabolites (Lei
et al, 2010; Mlynarik et al, 2008) and also to use such
methods to perform ischemia studies (Berthet et al,
2009). Although safety and other issues augment the
challenges of doing high field, in vivo NMR studies
of neonates and infants (De Vita et al, 2006; Dagia
and Ditchfield, 2008), one can still have the hope
that such will ultimately be available for individua-
lizing treatments with therapeutic hypothermia.
As an early step toward in vivo goals, we have
performed ex vivo experiments using a neonatal (P7)
rodent brain slice model, where insults, treatments,
and outcomes can be clearly defined and regulated.
Asphyxia was modeled by oxygen–glucose depriva-
tion (OGD), and two hypothermia protocols were
studied, along with a normothermia control. Tissues
were removed during and after hypothermia, and
high-resolution 14.1Tesla 1H/31P NMR spectroscopy
was used to determine changes in perchloric acid
extracted metabolite concentrations. We asked
whether NMR metabolic profiles of metabolite
ensembles could accurately differentiate treatments,
and good from bad outcomes, these being defined via
quantifications of cell death and ATP preservation,
with superoxide production helping to provide
assessments of OGD insults.
Materials and methods
Cerebrocortical Slice Acquisition and Superfusion
All animal experiments were approved by UCSF’s Institu-
tional Animal Care and Use Committee. Slice preparation
protocols were as described previously (Espanol et al,
1992; Zeng et al, 2007; Liu et al, 2008, 2009), with 20 350-
mm cerebrocortical slices coming from 10 anesthetized
7-day-old Sprague-Dawley rat littermates of either sex.
Excised slices were placed immediately in a superfusion
chamber containing fresh, oxygenated artificial cerebrosp-
inal fluid (oxy-ACSF) that consisted of a modified Krebs
balanced salt solution: 124mmol/L NaCl, 5mmol/L KCl,
1.2mmol/L KH2PO4, 1.2mmol/L MgSO4, 1.2mmol/L
CaCl2, 26mmol/L NaHCO3, and 10mmol/L glucose.
Continuous bubbling of oxy-ACSF with carbogen (95%
O2, 5% CO2) maintained constant values of PO2 (more than
E600mmHg), PCO2 (40mmHg), and pH (7.4). The oxy-
ACSF flow rate was 3mL/min. The chamber was partially
submerged in a water bath having a combined circulator-
temperature controller (PolyScience Standard Immersion
Circulator EW-12101-84, Cole-Parmer Instruments Inc.,
Vernon Hills, IL, USA; http://www.cole-parmer.com) that
maintained temperatures at either 371C (normothermic) or
321C (hypothermic).
Oxygen–Glucose Deprivation
Oxygen–glucose deprivation was initiated by replacing the
post-decapitation oxy-ACSF with glucose-free ACSF that
had been deoxygenated by equilibration with an anaerobic
gas mixture (95% N2, 5% CO2) at the required temperature.
During OGD, the oxygen content of the superfusate was
always < 2mmHg, as determined by a fiber-optic system
(FOXY-R probe and SF2000 Spectrofluorometer, Ocean
Optics Inc., Dunedin, FL, USA; http://www.oceanoptics.
com). The OGD period of 45minutes was followed
by 6hours of superfusion with oxy-ACSF containing
4mmol/L glucose.
Experimental Design
Four experiments with 45-minute OGD periods were
performed for each of the three groups: (1) Normothermia
(Group N), in which 371C was maintained during OGD and
a subsequent 6-hour recovery period. (2) Hypothermia
(Group H), in which slices underwent a rapid temperature
change from 371C to 321C (hypothermia) simultaneously
with the onset of OGD. Hypothermia continued throughout
OGD (45minutes) and afterwards throughout 3 hours
of recovery with oxy-ACSF. Following hypothermia
was 1hour of slow rewarming to 371C, achieved by
Abbreviations
ADP, adenosine diphosphate
ATP, adenosine triphosphate
Ala, alanine
Asp, aspartate
Arg, arginine
Cr, creatine
GABA, 4-aminobutyrate
Leu, leucine
NAA, N-acetyl-aspartate
NAG, N-acetyl-glutamate
PCr, phosphocreatine
Phe, phenylalanine
NADP+/NADPH, nicotinamide adenine dinucleo-
tide phosphate
The, threonine
Val, valine
The addition of ‘‘-1H’’ to a metabolite abbreviation
denotes the quantification of that metabolite in
proton spectra, rather than in phosphorous
spectra.
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increasing the bath temperature 0.11C per 1 to 1.5minutes.
Superfusion with oxy-ACSF continued at 371C for the last
2 hours of the experiment. (3) Delayed hypothermia (Group
D), where the group underwent the same cooling duration
and hypothermic treatment as Group H, except for having
the onset of hypothermia begin 15minutes after the start of
OGD. For all groups, five or six slices were removed from
the superfusion chamber for NMR or histologic analysis
at each of the four time points: before the onset of OGD (T0),
at the end of OGD (T1), at the end of hypothermia (T2), and
at the end of the experiment (T3). Figure 1 shows a
schematic diagram of the protocol.
Perchloric Acid Metabolite Extraction
Perchloric acid extraction and NMR tube loading were
performed as described in earlier studies (Espanol et al,
1992; Liu et al, 2008, 2009). In brief, frozen slices from each
time point were ground under liquid nitrogen in a
precooled mortar and then extracted using 30mL/g (dry
mass) of ice-cold 12% perchloric acid. The extracts were
neutralized to pH 7.0 with KOH and lyophilized for
24hours (BenchTop 2K lyophilizer, Virtis, Gardiner, NY,
USA). Before NMR analysis, lyophilized dry extracts were
weighted and stored at 801C and prepared for 1H
spectroscopy by resuspension in 430mL of D2O containing
0.02% 4,4-dimethyl-4-silapentane-1-sulfonic acid, a refer-
ence compound for NMR determinations of chemical shifts
and signal intensities. Samples were neutralized to pD 7.0
to 7.4, with DCl before being loading into 5mm NMR tubes
(Advanced Microtube CMS-005TB matched to D2O, Shige-
mi, Inc., Allison Park, PA, USA). After completing 1H NMR
spectroscopy, NMR tube contents underwent the addition
of EDTA and methylene diphosphonate (0.4mmol/L). The
former chelates cations that cause NMR line broadening,
whereas the latter served as a 31P NMR reference. The pD
was readjusted to 7.0 to 7.4 with NaOD before acquiring
proton-decoupled 31P NMR spectra.
Nuclear Magnetic Resonance Data Acquisition and
Analysis
One-dimensional NMR studies of extracts were performed
in the UCSF Magnetic Resonance Laboratory using a
14.1-Tesla (600MHz) Varian UNITY spectrometer, with
an INOVA console and a customized, multinuclear
Z-SPECT radiofrequency probe that was optimized for this
project (3NG600-8, Nalorac Division of Varian, Martinez,
CA, USA). Basic one-pulse RF sequences, as described
previously (Liu et al, 2009), were used for obtaining 1H
spectra at 599.92MHz and 31P spectra at 242.86MHz. The
extra homogeneity provided by 5mm Shigemi NMR tubes
Figure 1 Schematic diagram showing experiment time courses for each treatment group. Slice superfusion starts from the left
(t=3hours). After 3 hours of metabolic recovery is completed (t=0), a 45-minute oxygen–glucose deprivation (OGD) period
starts, and is then followed by 6 hours of reoxygenation, with hypothermia ending at t=3.75hours. Six predetermined times are
indicated above the rectangle. Brain slices were removed at the four times marked by vertical black arrows. Below the rectangle are
timelines for the three experimental groups: normothermia (red), hypothermia (green), and delayed hypothermia (blue). Hypothermia
and OGD began simultaneously for the middle group. The gray gradient bar between the bottom two timelines highlights the
15-minute delay that occurred before switching from a normothermic OGD superfusate to one at 321C. Both hypothermic groups
underwent the 321C treatment for 3 hours and 45minutes.
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and the Varian INOVA shimming software typically
resulted in spectral linewidths < 0.0025p.p.m. full width
at half maximum (1.5Hz full width at half maximum) for
1H water protons and 0.01p.p.m. full width at half
maximum for 31P in phosphocreatine. Proton spectra were
composed from 64 transients, with a 4-second acquisi-
tion time and a 1-second interpulse delay. A selective
saturation pulse was used to suppress the water peak.
Metabolites corresponding to different chemical shifts
were identified and quantified with Chenomx NMR Suite
Software (version 6.0, Chenomx Inc., Edmonton, AB,
Canada) using targeted profiling (Weljie et al, 2006) and
their spectral library for 600MHz, whose pulsing para-
meters were used when acquiring our spectra. For each
metabolite, the targeted profiling approach involves
manual simultaneous adjustment of all resonance peak
clusters for that metabolite. For example, quantification of
the 1H doublet resonance peak at 1.33p.p.m. (often referred
to simply as ‘lactate’) required manipulation of clusters
for both lactate and threonine, as the latter overlaps with
lactate at that chemical shift. This involved manually
fitting portions of the observed spectrum by coordinating
simultaneous adjustments of both lactate peaks (the
doublet at 1.33 p.p.m. and the quartet at 4.12 p.p.m., with
simultaneous adjustments of all three threonine peaks
(the doublet at 1.33p.p.m., the doublet at 3.58p.p.m., and
the multiplet at 4.26 p.p.m.). All chemical shift assign-
ments for peaks and clusters were then checked against
chemical shift assignments published in careful studies
(Govindaraju et al, 2000; Willker et al, 1996), and
also listed in computer databases at the University of
Wisconsin’s Biological Magnetic Resonance Data Bank
(Standard Compounds; http://www.bmrb.wisc.edu/meta
bolomics), and at the National Institute of Advanced
Industrial Science and Technology (http://www.aist.go.jp/
RIODB/SDBS) in Japan. 31P and 1H relaxation time
corrections were not introduced, as the same NMR pulse
sequence was used for all runs of the same nucleus, and
the goal of the analysis was primarily to detect large
differences in each metabolite from its control value.
Metabolite signal intensities were computed relative to
methylene diphosphonate or 4,4-dimethyl-4-silapentane-
1-sulfonic acid, and then normalized to the weight of
the dry powder that was mixed with D2O before NMR
Figure 2 (A, B) Sections of one high-resolution 600MHz 1H
nuclear magnetic resonance (NMR) spectrum of a perchloric
acid extract from rat brain slices taken at T0, which is just before
the oxygen–glucose deprivation (OGD) insult. A 0.1-Hz line
broadening was applied. Each labeled resonance peak was
manually identified with Chenomx NMR Suite Software, care-
fully checked against online databases, and then fit, with all
resonance clusters from a particular metabolite being adjusted
simultaneously, as described in the text. (A) 0.5 to 4.5 p.p.m.:
resonance peaks upfield (right side) of the water peak at
4.67 p.p.m. An enlarged insert view shows that PCr and Cr are
resolvable in the 1H spectrum. Metabolite assignments are
shown; (B) 5.0 to 9.0 p.p.m.: resonances downfield (to the left)
of the water peak. Some high-energy metabolites, ATP, ADP,
and NADP, can be clearly identified and quantified in this region.
(C–F) Sections of a representative 31P spectrum: (C) The aADP
resonance is clearly separated from the aATP resonance. The
separated aADP doublet can be seen to have overlapping
contributions from aGDP, aCDP, and aUDP. These regions are to
the right of aADP and their contributions are small. (D) The large
doublet cluster is gATP, clearly separated from the doublet bADP
peak to its right. (E) A typical bATP resonance peak is shown as
a large triplet cluster at approximately 18.4 p.p.m. in this
spectrum. The chemical shift of the sharp phosphocreatine (PCr)
peak was always set at 0 p.p.m. (F) Four membrane-related
metabolites are marked: phosphoethanolamine (PE), phospho-
choline (PC), glycerol 3-phosphoethanolamine (GPE), and
glycerol 3-phosphocholine (GPC).
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measurements. 1H NMR spectral analysis provided
quantifications of 39 metabolites: 4-aminobutyrate, ADP-
1H, ATP-1H, acetate, adenine, alanine, arginine, aspartate,
choline, citrate, creatine, phosphocreatine, formate, fuma-
rate, glucose, glutamate, glutamine, glutathione, glycine,
inosine, isoleucine, lactate, leucine, malate, N-acetyl-
aspartate, N-acetylglutamate, NADP+, NADPH, phospho-
choline, phosphoethanolamine, phenylalanine, phthalate,
succinate, taurine, threonine, tryptophan, tyrosine, valine,
and myo-inositol. Figures 2A and 2B show a typical 1H
NMR spectrum for extracts obtained from slices taken at
T0 (just before starting OGD). The insert with spectral
expansion illustrates the system’s outstanding 1H NMR
spectral resolution by showing that the methyl protons in
creatine are resolved from the methyl protons in phospho-
creatine. 31P NMR spectra that were analyzed similarly,
using published chemical shifts (Pettegrew et al, 1993),
provided additional metabolite measures: ATP, ADP,
phosphocreatine, phosphoethanolamine, glycerophospho-
ethanolamine, phosphorylcholine, and glycerophospho-
choline. Overlapping 31P resonances were quantified by
deconvolution with iNMRTM software (Mestrelab Research,
Santiago de Compostela, Spain, www.inmr.net.). Figures
2C–2F display typical 31P NMR spectral peaks, also from
slices taken at T0.
In Situ Detection of Superoxide Production
Hydroethidine (HEt; D1168, Invitrogen, Carlsbad, CA,
USA) is freely permeable to living cells and selectively
oxidized by the superoxide anion to red fluorescing
ethidium (Et). The protocol followed the methods pub-
lished in an earlier study (Liu et al, 2008). In brief, a
parallel superfusion channel with an independent ACSF
reservoir containing 5 mmol/L HEt was established for this
procedure. The channel was identical to that for the
original superfusion chamber, except for there being HEt
in the superfusate. Thirty minutes before selected time
points during perfusion of experiments, three slices were
transferred from the original superfusion chamber into the
parallel chamber for superfusion with ACSF containing
HEt. After 30minutes of incubation, slices were removed
and fixed overnight in freshly prepared 4% formaldehyde
at 41C. On the following day, the slices were dehydrated in
30% sucrose, and then washed twice in PBS and
immediately embedded in O.C.T. (Sakura Finetek Opti-
mum Cutting Temperature compound, OpticsPlanet Inc.,
Northbrook, IL, USA), and cut into 10-mm-thick sections on
a cryostat (Leica, CM1900, Solms, Germany). Mounting
medium containing 1.5mg/mL 40,60-diamidino-2-phenylin-
dole (H1200; Vector Laboratories, Burlingame, CA, USA)
was applied onto sections to counterstain cell nuclei.
Superoxide anion production was assessed in a Leica SP2
Laser scanning confocal microscope at UCSF Diabetes
Center’s Facility for Microscopy and Cellular Imaging, with
excitation wavelengths being 510 to 550nm and emission
wavelengths > 580nm for Et fluorescence. There was no
wavelength overlap for the imaging of 40,60-diamidino-2-
phenylindole, whose excitation and emission wavelengths
are, respectively, 350 and 470nm when bound to DNA.
Quantifications of Et-positive cells were performed at five
random regions between the pial layer and the injury layer
of brain slices. These regions were photographed under
a  63 oil immersion objective, and cell counts included
neurons and glia, these not being histologically distin-
guishable. Counts of Et-positive cells are given as percen-
tages of total cells counted.
Terminal Deoxynucleotidyl Transferase-Mediated
2’-Deoxyuridine 5’-Triphosphate-Biotin Nick End
Labeling Staining and Enzyme-Linked Immunosorbent
Assay DNA Fragmentation Assay
Evidence for apoptosis in slices taken at different time
points was examined both with fluorescence microscopy
of in situ terminal deoxynucleotidyl transferase-mediated
uridine 50-triphosphate-biotin nick end labeling (TUNEL)
staining and with quantification using a sensitive, commer-
cial, enzyme-linked immunosorbent assay (ELISA) (Cell
Death Detection ELISAPLUS, Roche Applied Science, India-
napolis, IN, USA).
For TUNEL staining, sections were first permeabilized
in 0.1% Triton X-100 (Sigma Chemical Co, St Louis, MO,
USA) in PBS for 8minutes. The TUNEL reaction mixture
was obtained by adding terminal deoxynucleotidyl trans-
ferase to the nucleotide mixture according to the instruc-
tions in the manufacturer’s manual (Roche Diagnostics,
Mannheim, Germany). Each section was then incubated
with 50 mL TUNEL reaction mixture in a humidified, dark
chamber at 371C for 60minutes. After rinsing with PBS,
sections were counterstained with 0.5mg/mL propidium
iodide to highlight nuclei. The fluorescein wavelength for
excitation was 488nm, with emissions being detected above
515nm. Propidium iodide excitation was at wavelengths
<535nm, with emission being detected at B615nm.
The ELISA assay, which was performed according to
the manufacturer’s instructions, detects apoptotic but
not necrotic cell death (Leist et al, 1998) via antibody
identification of histone-associated DNA fragments. A
quantitative sandwich enzyme immunoassay is performed
using mouse monoclonal antibodies directed against DNA
and histones. Nucleosomes, which package DNA within
chromosomes, are composed of large numbers of linked
histones, the proteins onto which DNA is wrapped. During
apoptosis, endonuclease cleavage of double-stranded
DNA occurs at the most accessible locations, the inter-
nucleosomal linker regions, thereby generating mono- and
oligonucleosomes having DNA with multiples of 180
basepairs. (As the DNA within nucleosomes is tightly
complexed to the histones, it is protected from cleavage
during apoptosis.) The quantification by this assay is thus
analogous to the quantification of ‘ladder patterns’ via
DNA electrophoresis.
Briefly, the manufacturer’s protocol involved the follow-
ing: one snap-frozen cerebrocortical slice was homo-
genized in lysis buffer, incubated for 30minutes, and then
centrifuged. The supernatant, which contained apoptotic-
related DNA fragments released from the cytoplasm, was
transferred into the well of a streptavidin-coated micro-
plate for 2hours of incubation at room temperature. Within
the well, an anti-histone antibody and an anti-DNA
antibody were used to form and immobilize antibody–
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nucleosome complexes. After washing and adding peroxi-
dase substrate in the well, the anti-nucleosome complexes
were quantified in a spectrophotometer with absorbance at
405nm. To account for variations of slice size and cell
numbers, spectrophotometer quantifications for each slice
were normalized to the total protein concentration in
that cell’s lysate. The assay was performed three times for
each particular time point, using three different slices, for
all time points (T0, T1, T2, and T3) of each treated group.
Statistical and Metabolomic Analyses
The NMR metabolite quantifications for all particular time
points for all experimental groups underwent within-group
and between-group statistical analysis. Different multi-
variate approaches were used, as further explained below,
including: Fisher’s protective least squares difference test
for multiple comparisons, principal component analyses
(PCA), projection to least squares discriminant analyses
(PLS-DA), and the L1-penalized regression algorithm
(Efron et al, 2004; Tibshirani, 1996).
For each time point, pairwise comparison testing for
differences in individual metabolites and cell-death quan-
tifications was performed between treatment groups.
Metabolites for the last three time points were normalized
to initial values, these being taken as the control in each
experiment. Thus, there were nine tests for each metabo-
lite, and also for cell-death quantifications: N (normo-
thermia) versus D (delayed hypothermia), N versus H
(hypothermia), and H versus D, that is, three comparisons
for each of the times T1, T2, and T3.
SIMCA P+ v.11 software (Umetrics, Inc., San Jose, CA,
USA) was used for determining PCA and PLS-DA compu-
tations. Briefly, as described in Umetrics publications
(Eriksson et al, 2006), the SIMCA P+ approach begins by
mathematically creating an N-dimensional space, where N
is the number of independent variables in the metabolite
ensembles being compared. For comparisons of each time
point’s ensemble of 1H NMR metabolites, N is 39. When
NMR data for a single time point also includes metabolites
determined in 31P spectra, N becomes 49. Thus, each set of
39 or 49 numbers for a particular slice-removal time is
represented by a single point in a 39- or 49-dimensional
space. In the PCA, all metabolite data undergoes centering
and unit variance scaling, after which the plane is found
whose two orthogonal axes have maximum cluster separa-
tions when data points are projected onto it. Two-
dimensional scores plots are used to display the clusters
in planes where the x and y axes are principal components.
In the PLS-DA, an algorithm sharpens the PCA clusters and
their separations by creating a new Y variable for each data
class (Eriksson et al, 2006). The scores plots in the PCA and
PLS-DA analyses have corresponding loadings plots that
identify metabolites that contributed most to the separa-
tions that appear in the scores plot. In the scores plot, each
spectral data set is plotted as a point, which in turn defines
a vector from the origin. Each such vector, however, is the
vector sum of 39 or 49 smaller vectors defined by the
metabolites. Projections onto the plane of the principal
axes of those smaller metabolite vectors produces the
loadings plot or weight plot. Although any data collection
can be put through a PLS-DA analysis, the usual use in this
type of study is to focus data sets that best compare
outcomes. Thus, we will focus on the PLS-DA analysis for
one data set, that for metabolites at the last time point (end
of the experiment), with each metabolite value expressed
as its ratio to the starting value (after normalization of each
slice ensemble to its dry weight).
After Umetrics software processing, NMR-detected me-
tabolites were analyzed independently with L1-penalized
regression (Goeman, 2010; Tibshirani, 1996), a multivariate
algorithm in which one identifies a priori one or more
‘outcome’ measures, and then, in a regression analysis,
minimizes L1, the sum of absolute values of the residuals.
All data for all time points are used, with identification of
metabolite subsets that have the strongest influence on the
‘outcome’ variable(s). This was performed twice, first with
there being only one outcome variable, bATP, and then
again with the only outcome variable chosen to be the cell-
death measure quantified by the ELISA analysis. When
taking bATP as the outcome variable, the analysis did not
include 31P-based metabolites. The motivation for using an
L1 penalty (minimizing absolute deviations) in estimating
regression coefficients is, in biostatistics terminology, that
this specification simultaneously imparts a shrinkage (of
the size of the set of final variables) that results both in
improved predictive performance, and in a covariate
selection that has improved interpretability.
The geometric underpinnings for this algorithm’s beha-
vior are detailed in Tibshirani (1996), who terms the
procedure LASSO: Least Absolute Shrinkage and Selection
Operator. However, the original LASSO algorithm can
breakdown when the number of covariates (metabolites)
exceeds the number of samples, as here. In such settings,
the recently devised, and highly efficient, LARS (Least
Angle Regression) algorithm (Efron et al, 2004) can be
applied. Indeed, the inherent instabilities associated with
small sample sizes and relatively many predictors, often
correlated—as in our data sets—accentuates the impor-
tance of such shrinkage and selection. In a LARS analysis
the tradeoff between model fit, which for continuous
outcomes such as bATP or the ELISA quantifications is
measured via residual variance, and model complexity,
arising here from the number of selected metabolites, is
governed by a tuning parameter that weights the contribu-
tion of the L1 penalty. Determination of the value of the
tuning parameter makes recourse to cross-validation
(Hastie et al, 2010). Briefly, the tuning parameter value
that achieves optimal fit is selected from evaluations over
unseen data furnished by the cross-validation data parti-
tioning approach. The choice of the tuning parameter
determines which and how many metabolites to retained.
Results
High-Energy Phosphate Outcomes from 31P Nuclear
Magnetic Resonance Spectra
The vertical bar plot in Figure 3A displays ATP, ADP,
and PCr values for slices taken at the three experi-
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mental time points (end of OGD, end of hypothermia,
and end of experiment) measured relative to initial,
pre-insult values (first time point). It shows that at
the end of OGD, the time of maximal metabolic
stress, ATP, ADP, and PCr decreased, respectively, to
B15%, 40%, and 5% of control. Figure 3B shows
that at the end of the recovery period, that is, at
the conclusion of the experiment, some 6hours
after ending OGD, values of ATP, ADP, and PCr
were significantly lower in the normothermia group
than in the hypothermia and delayed hypothermia
groups, each of which exhibited recovery to control
levels. As well, Figure 3B shows that levels
of membrane phospholipids PE, GPE, PC, and GPC
had similar behavior. However, it should be appre-
ciated that when metabolite values decrease by 40%,
as was the case for the final ATP for the normother-
mia group, NMR spectroscopy cannot distinguish
between a uniform 40% loss among all cells, and the
situation where 40% of the cells lost all ATP while
60% lost none.
Metabolite Changes from 1H Nuclear Magnetic
Resonance Spectra
Similar vertical bar plots for 1H metabolites, shown
only for the end of the recovery period, are displayed
in Figure 3C for 39 metabolites. As in the 31P NMR
analysis, the level of ATP and PCr decreased
substantially in the normothermia group. In addi-
tion, compared with their values in the normother-
mia group, NAA, glutamate, and taurine increased
significantly in both the hypothermia and delayed
hypothermia groups. Metabolites that were sup-
pressed in hypothermia and delayed hypothermia
groups included acetate, adenine, alanine, choline,
isoleucine, lactate, leucine, tyrosine, and valine
Figure 3 31P and 1H nuclear magnetic resonance (NMR) changes relative to control for three treated groups. See the text for
computational details. (A) ATP, PCr, and ADP quantifications relative to control for three sampling times (T1, T2, and T3).
(B) Normalized final to initial ratios for the 10 31P metabolites that were quantified. Asterisks denote statistically significant
differences (*P<0.05). Data are plotted as mean±s.d. (n=4). (C) Normalized final to initial ratios for the 39 1H metabolites
that were quantified. Values are shown as mean±s.e. (n=4). Statistical analysis for these plots included an analysis of variance to
rule out the null hypotheses, followed by the Fisher’s protected least significant difference post hoc test.
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(inosine and arginine decreased only in the hy-
pothermia group).
Metabolomic Analyses I: Projection to Least Squares
Discriminant Analyses Scores and Loading Plots
Figure 4A shows the PLS-DA scores plot (Eriksson
et al, 2006) produced for the final time point by the
SIMCA P+ multivariate analysis, which mapped
each NMR spectrum or data set into a single point in
a multidimensional space, and then looked for
planes where the points formed distinct clusters.
The data set that resulted in Figure 4A consisted of
the ratio of final to initial NMR intensities for each
metabolite, including both 1H and 31P metabolites.
The scores plot clearly shows a tendency for separate
clustering by the three treatment groups: normo-
thermia (blue), hypothermia that starts with OGD
(black), and hypothermia that starts after a 15-minute
delay (red). The x and y axes of the plot are the two
‘principal component’ axes. Figure 4B shows the
loadings plot (Eriksson et al, 2006) that corresponds
to the scores plot. Metabolites in each quadrant of
the loadings plot correspond to points in the same
quadrant of the scores plot. Metabolites that are close
together on the loadings plot are highly correlated,
and metabolites furthest from the origin contri-
buted most to the furthest points in the scores plot.
For example, lactate and alanine are close to each
other in the lower left quadrant of the plot, as are
glycerophosphocholine and glycerophosphoethanola-
mine, and ATP and ADP in other quadrants, and each
of these metabolites was influential in the scores plot.
Terminal Deoxynucleotidyl Transferase-Mediated
2’-Deoxyuridine 5’-Triphosphate-Biotin Nick End
Labeling Staining and Enzyme-Linked Immunosorbent
Assay DNA Fragmentation Assay
The TUNEL-positive cells, which contain DNA frag-
mentation, were too few for cell counting. Figure 5
illustrates the help provided by costaining with
propidium iodide in discerning when morphology
in TUNEL-positive cells was suggestive of apoptosis
(condensed, fragmented nuclei) and necrosis (diffu-
sely stained nuclei). The ELISA DNA fragmentation
quantifications, also in Figure 5, show that both at
the end of the experiment and also at the time
when hypothermia had been completed, cell death
was significantly lower in the hypothermia group
compared with the normothermia and delayed
hypothermia groups, which had statistically similar
values. In contrast, at the end of OGD, the nor-
mothermia group had significantly greater death than
either of the two lower temperature groups, which
had statistically similar values.
Metabolomic Analyses II: L1-Penalized Regression
Cross-validation prediction error (CVPE) profiles
from applying L1-penalized regression to bATP and
apoptotic cell death are given in Figures 6A and 6B,
respectively. (This analysis did not include 31P-based
metabolites.) As noted earlier, in this analysis,
data are pooled from each of the four repetitions of
three groups, each with three time points. Thus,
the sample size had 36 data sets, which is close to
the number of NMR-determined metabolites. The
Figure 4 (A) The scores plot and (B) the loading plot as described in the text for the final to initial metabolite ratios. (A) Blue X’s
correspond to normothermia, black squares correspond to hypothermia, and red circles correspond to delayed hypothermia. (B) Red
letters show positions for the new Y variables defined in the SIMCA P+ analysis.
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number of variables chosen for calculating CVPE is
plotted along the x axis as ‘the fraction,’ which is the
ratio of the number of chosen variables to the total
number of available variables (39 1H metabolites).
The y axis gives the CVPE obtained when the number
of independent variables is that indicated
by the corresponding value on the x axis. Thus, the
ELISA outcome results are best fit when the NMR
data set is taken to have six variables (x=0.15, with
39 variables), whereas the bATP outcome results
suggest that as many as 12 variables are needed for
a best fit. Both profiles are prototypic in that they
exhibit initial decreases in CVPE as the value of
‘fraction’ starts to increase from 0 as important
metabolites are entered; and then show almost no
CVPE changes with further increases in ‘fraction,’
indicating that several statistical models attain
approximately equal and minimal CVPE; and finally
show ever increasing values of CVPE as noise
variables are included. Several heuristics have been
advanced for selecting a specific model based on
such profiles. These include taking the number of
metabolites to be that associated with minimum
CVPE, or by finding a smaller model (fewer metabo-
lites) by taking the smallest number of metabolites
associated with a CVPE value that is within one
standard error of the minimum CVPE. With bATP as
the outcome variable, the top five metabolites were
PCr (as seen in 1H spectra), ATP-1H, choline, formate,
and phosphoethanolamine. The next five metabolites
Figure 5 Representative slice sections obtained with fluorescence confocal microscopy and double stained with propidium iodide
(red) and the terminal deoynucleotidyl transferase-mediated 2’-deoxyuridine 5’-triphosphate-biotin nick end labeling (TUNEL) stain
(green). Compared with control (A), cells in the hypothermia group (B) were only slightly more swollen, and generally of the same
appearance. In contrast, cells of the normothermia group (C) showed greater deterioration. The TUNEL-positive cells were too few to
count and were primarily in the normothermia group. Instead of cell counting, an enzyme-linked immunosorbent assay (ELISA)
sensitive to DNA fragmentation was used, as described in the text. The bar graph at the lower right shows ELISA quantifications
(N=3), with cell death clearly greater at the end of the experiment for both the normothermia and delayed hypothermia groups,
these having equal death within experimental errors. Statistical analysis included an analysis of variance to rule out null hypothesis,
followed by the Fisher’s protected least significant difference post hoc test. Data represent mean±s.d. Asterisks indicate P<0.05
significance.
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that would be allowed by going lower in ‘fraction’ are
malate, fumarate, ADP-1H, threonine, and glutathione.
With the ELISA measure of cell death as the outcome
variable, the top five metabolites were: ADP-1H, valine,
acetate, tryptophan, and formate, with these followed
by phosphocreatine and leucine. In the analysis where
cell death was the outcome variable, the inclusion of
31P-based metabolites did not change the results.
In Situ Superoxide Production
Figure 7A shows selective, high-magnification con-
focal fluorescence imaging of superoxide, detected
from its oxidation of HEt to Et (red fluorescence).
Cross-sections 0.1 mm thick are shown through
central slice regions, with cell nuclei appearing
blue from 40,60-diamidino-2-phenylindole staining.
Figure 7B plots superoxide quantifications for the
hypothermia and normothermia groups, obtained for
four time points as described in the Materials and
methods. Superoxide, which barely existed in con-
trol slices, became incrementally greater with time,
and always more so in the normothermia group.
Discussion
Our brain slice preparation’s advantages for model-
ing neonatal asphyxia include: that its neuron-glia
architecture is close to that found in vivo, that the
arrangement very conveniently accommodates ultra
rapid freeze clamping of metabolites and cellular
processes, and that it is easy to have tight control of
PO2, PCO2, pH, temperature, and superfusate com-
position. We chose a hypoxia protocol with contin-
uous superfusate flow, as continuous brain tissue
perfusion is a key feature of the widely used
Vannucci–Rice in vivo model of neonatal asphyxia
(Vannucci et al, 1999; Vannucci and Vannucci,
2005). Glucose is well known to provide enormous
anoxic protection to rat astrocytes during early
development. In one astrocyte, cell culture study
using 15mmol/L glucose, 24 hours of total oxygen
deprivation produced zero cell death (Callahan
et al, 1990). Because of this and preclinical rodent
studies that found decreases in both brain and
plasma glucose during asphyxia (Basu et al, 2009;
Holowach-Thurston et al, 1974), we felt that glucose
deprivation was appropriate in our model. A dis-
advantage of acute brain slice preparations is that
treatment times and post-insult recovery times
are short compared with those for in vivo studies,
where multiple mechanisms contribute to cell death.
If, however, early, distinct metabolomic differences
are seen clearly, it will be reasonable to look for such
differences in vivo.
Knowing that almost all chemical reactions are
affected by temperature changes, we felt that a
multivariate metabolomic approach with simulta-
neous monitoring of 30 to 40 metabolite concen-
trations would lead to group parameters that distin-
guished metabolite ensembles associated with less
injury and better outcomes. Despite our having far
fewer data points per treatment group than used in
traditional multivariate studies, the scores plots of
Figure 6 Cross-validation prediction error (CVPE) profiles.
Separate analysis was performed for each of the two outcome
variables, these being the ratio of final to initial ATP (A), and the
enzyme-linked immunosorbent assay (ELISA) cell-death quanti-
fication (B). In each analysis, all data from all time points were
processed in an L1-penalized regression. The y axis gives the
CVPE that results when the model tries having n independent
metabolite variables to fit the data, with n being the abscissa
along the x axis. Instead of being given as an integer, n is given
as a fraction of the total number of metabolites. Thus in (B), the
lowest CVPE value corresponds to the ‘fraction’ being 0.154,
which in turn corresponds to having the outcome variable
dominated by the behavior of six metabolites, when data for
39 metabolites are the input to the analysis. For each value
of CVPE, one can look up which metabolites were found to be
most important.
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the PLS-DA showed clear separations, suggesting
that multivariate characterizations are potentially
useful. This phenomenon has been demonstrated
previously in earlier works by us and others (Liu
et al, 2009; Serkova and Niemann, 2006a; Serkova
et al, 2006b; Jordan et al, 2009). Naturally, one
expects that future accumulations of many more data
points would lead to overlapping distributions,
despite the cluster shrinkage and higher resolution
of cluster separations provided by going from the
PCA to a PLS-DA analysis. The separation of
treatment groups on a metabolomics PLS-DA plot,
however, is not the final step.
Although particular treatment groups might form
distinguishable clusters on scores plots that possibly
end up being consistently associated with better or
worse biological outcomes, an analysis is needed
that starts with outcome values and assesses the
extent to which they were optimized by all or some
of the biomarkers. The L1-penalized regression
analysis, which for reasons already given was used
instead of a PLS-DA or partial least squares regres-
sion (Eriksson et al, 2004; Wold et al, 2001),
produced impressive differences with the two out-
come variables that we chose: early cell death as
measured by an ELISA, and ATP preservation, as
measured by 31P NMR spectroscopy (while excluding
all other 31P NMR data). Although the use of the
ELISA assay as an outcome variable worked well in
this particular study, interpretations of ELISA quan-
tifications in this study is limited by a lack of
calibration. The ELISA changes are measured rela-
tive to baseline values, not relative to the maximal
apoptotic stimulus. Thus, if overall cell death is
small at baseline, for example 10%, a 40% increase
in ELISA represents only a 4% increase in overall
cell death.
It is easy to conclude that taking ATP preservation
as the sole outcome variable would not be very
helpful in our model, as the two hypothermia treat-
ment groups totally restored their initial high-energy
phosphates while having large differences in early
cell death. This is also apparent from the L1-pena-
lized regression, which found that 12 metabolites
of 39 1H metabolites were very important to ATP
optimization. In contrast, early cell death had
significant differences between the two hypothermia
treatment groups with only six key metabolites, with
two being 1H-detected high-energy phosphates. The
data support the notion that early ATP recovery does
not imply that all is well at cellular levels. Although
ATP preservation after 6 hours of recovery, the time
when our experiments finished, might not be very
helpful as an outcome variable, in experiments that
go out to much later times it might nevertheless have
associations more meaningful than those of ELISA
measurements, which are based on caspase-initiated
endonuclease cleavage at internucleosomal linker
regions (presumably before ATP depletion). After
6 hours of recovery, ELISA measurements might
account for only a fraction of the dying neurons.
After OGD, eventual ATP depletion from necrosis
and caspase-independent pathways can be more
prominent at later times, as noted in two earlier
studies (Bonfoco et al, 1995; Kalda et al, 1998).
From a metabolomic perspective, the data suggest
that the detection of ‘downfield’ 1H metabolites
(1H resonances to the left of the H2O peak) can add
much to metabolic monitoring and predicting. Such, of
course, is very easy in extract spectra, and much more
challenging in vivo. Nevertheless, data have appeared
that show in vivo detection with current techniques is
within reach (Vermathen et al, 1999), and that accurate
ex vivo detection in tissues is more easily attainable
(Fris and Midelfart, 2007). As acquisition of 31P NMR
spectra can easily require times that are longer by a
factorX10, it would be very significant to be able to
obtain the same or better analyses with only 1H data.
We considered treating superoxide quantifications
as an outcome variable or an additional biomarker
measure of insult, but had to hold back because HEt
fluorescence detection of superoxide is so sensitive a
technique, that noninjurious perturbations, such as
isoflurane anesthesia with no insult, can produce
HEt images similar to those in this paper (Tanaka
et al, 2003). We also considered having an experi-
mental group in which therapeutic hypothermia was
initiated at the end of the 45-minute OGD period.
Preliminary data (not shown) strongly suggested, as
might be surmized from Figure 3, that one would not
Figure 7 (A) Comparison of ethidium (Et) fluorescence (red) with 40,60-diamidino-2-phenylindole (blue) nuclear counterstaining.
(B) The graph at the right compares quantifications (N=4 for each T) of red relative to blue for the four-slice sampling time points.
Data represent mean±s.d. (n=4). Asterisks indicate significance compared with the normothermia group by the unpaired t-test.
P<0.05.
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find this group’s ATP results to be distinguishable
from the normothermia results.
In conclusion, in the presented OGD brain slice
model of neonatal asphyxia, normothermic tissue
suffered ATP losses and cell death, but tissue given
a 41C temperature decrease preserved ATP levels,
whether the temperature change was applied at the
start of OGD or 15minutes later. However, cell death
was substantially reduced only when the temperature
decrease was simultaneous with the OGD onset.
Although the metabolomic analyses found that the
different treatment groups were forming separate
clusters, larger data samples and improved choices of
outcome variables are needed for further mechanistic
insight.
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Appendix on the Arrhenius equation
Many preclinical studies have found that after brain
hypoxia/ischemia, outcomes can be dramatically
improved by mild therapeutic hypothermia, with
temperature decreases typically of only 41C. Given
that body chemistry is occurring at an absolute
temperature of B3091K, a 41C decrease is only a
1.3% change. What makes it possible for small
temperature changes to be so important?
The answer can be found in the Arrhenius equation
for the rate constant K of any chemical reaction A-B:
K= (a constant) exp([activation energy]/[kT])
The ‘activation energy’ normally equals the thresh-
old energy, because contributions from the mean
thermal energy are normally extremely small compared
with reaction energies (Menzinger and Wolfgang,
1969). In such situations, the activation energy does
not change with temperature, and the rate constant has
exponential behavior with (1/T). Earlier studies based
on temperature independence of the activation energy
found that a decrease of 41C would lower the human
cerebral metabolic rate by B28% (taking Q10=2.3),
and the rat cerebral metabolic rate by 63% (taking
Q10=12). However, near reaction thresholds the
activation energy can be a function of temperature,
and dramatic reaction rate changes can occur within a
41C temperature interval, if chemical reaction thresh-
olds are crossed in that interval. If, for example, the
increase of a few degrees allows greater opening of
hundreds of hydrogen bonds, reactions that depend on
those bond openings will be greatly facilitated.
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